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ABSTRACT 
 
Optical Perfusion and Oxygenation Characterization in a Liver Phantom.  
(December 2011) 
Travis J. King, B.S., Louisiana Tech University 
Chair of Advisory Committee: Dr. Gerard L. Coté 
 
 
 
Continuous monitoring of blood perfusion and oxygenation is essential in 
assessing the health of a transplanted organ. Particularly, monitoring the perfusion and 
oxygenation of the organ during the two-week period after the transplant procedure is 
crucial in detecting a sustained loss in perfusion or a reduction in oxygen saturation 
before these changes render irreversible damage to the organ or patient. Pulse oximetry 
is a clinically accepted method of monitoring the arterial oxygen saturation of a patient 
in a non-invasive manner. Pulse oximeters exploit the wavelength-dependent absorption 
of oxygenated and deoxygenated hemoglobin to measure a patient’s arterial oxygen 
saturation. However, traditional pulse oximeters do not provide perfusion information 
and produce erroneous oxygen saturation measurements under low perfusion levels.  
An optical blood perfusion and oxygenation sensor, based on a modified 
reflectance pulse oximeter, has been developed for in situ monitoring of transplanted 
organs.  To reduce the number of animal experiments, phantoms that mimic the optical 
and anatomical properties of liver parenchyma have also been developed. In this work, 
in vitro data was gathered from dye solutions mimicking oxygenated blood that were 
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pumped through single and multi-layer phantoms mimicking liver parenchyma and 
through a phantom mimicking the portal vein. A portion of the phantom data was 
compared to data collected from in vivo occlusion studies performed on female swine to 
assess the ability of the phantoms to mimic the response observed with changes in blood 
perfusion through liver parenchyma. Both the single layer and multilayer phantoms 
showed a similar response to changes in perfusion as the in vivo case. With each 
phantom, the signal increased linearly with increases in perfusion, but the multilayer 
phantom showed a higher sensitivity (approximately 30% higher) to changes in 
perfusion than the single layer phantom. This higher sensitivity would provide the ability 
to measure smaller changes in perfusion and increase the resolution of the sensor. Also, 
both parenchymal phantoms showed similar trends in the oxygenation studies, with the 
R value decreasing with increasing oxygenation. While the observations in this research 
demonstrate the ability to use both phantoms for in vitro experiments, the results show 
the multilayer phantom is a better option for mimicking perfusion because it displays 
similar occlusion patterns as the liver parenchyma in vivo, a higher sensitivity to changes 
in perfusion than the single layer phantom, and it is only slightly more complex in 
design (contains only two more layers of sinusoids) than the single layer phantom. 
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CHAPTER I  
INTRODUCTION 
According to the Scientific Registry of Transplant Recipients (SRTP) and the 
Organ Procurement and Transplantation Network (OPTN), the number of patients on the 
waiting list for a liver transplant as of July 2011 is 16,169, but the number of liver 
transplant procedures performed in 2011 is 2,037 (based on OPTN data as of July 20, 
2011). These numbers suggest that the number of available donor organs is failing to 
meet the patient demands. One-year graft survival rates from living and deceased donors 
were 84.3% and 86.6%, respectively, between 2006 and 2007 [1]. Therefore, there is a 
need to minimize graft loss and increase the success rate of liver transplant procedures. 
This increase in the success rate should lead to a decrease in the demand for livers.  
A means of monitoring the status of the transplanted organ over time is important 
in noticing trends that suggest a failing graft and organ. A common cause of organ 
failure is complications due to graft failure, and a common cause of graft failures is 
ischemia, which is often caused by Hepatic Artery Thrombosis (HAT) and Portal Vein 
Thrombosis (PVT) [2]. Due to a limited availability of cadaveric organs and an 
increasing number of patients being added to the waiting each year list, portions of liver 
from living donors are being used in transplant procedures. However, the use of this 
method increases the likelihood that PVT or HAT will occur. A prolonged decrease in 
blood flow to the transplanted organ can result in loss of organ function, which can be 
____________ 
This thesis follows the style of Biomedical Optics Express.  
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hazardous to the patient and will require additional surgical procedures to be performed 
to save the organ or, in the most extreme cases, save the patient. The 7-10 days 
following the transplant procedure proves to be the most critical in assessing the health 
of the organ. It is within this time period that physicians can assess the health of the 
organ and determine if additional surgical procedures are necessary to save the organ. 
The ability to monitor blood perfusion to the organ during this critical time period will 
allow physicians to detect trends in the perfusion that suggest a failing organ and address 
the issue before the damage to the organ becomes irreversible. The increase in graft 
survival will be beneficial in preventing multiple transplant procedures from being 
performed, which will decrease the loss of donor organs, and decreasing the loss of 
donor organs is important given the number of patients on the waiting list.  
In order to detect blood perfusion and oxygenation of an implanted organ, the 
Optical Biosensing Laboratory at Texas A&M University, in collaboration with Oak 
Ridge National Laboratories and the University of Pittsburgh is developing an in vivo 
sensor. The sensor, based on a modified reflectance pulse oximeter, is envisioned to be 
the size of a quarter to allow it to be implanted onto the surface of the transplanted organ 
during the recovery period. The signal measured by the sensor is proposed to be sent to a 
nearby desktop computer via wireless telemetry for signal processing [3-7]. 
To facilitate sensor design while minimizing animal experiments, it is useful to 
test the sensor on a phantom that mimics the optical and flow properties of the liver 
parenchyma. A phantom developed by Ruiqi Long et al. has been shown to mimic the 
optical and anatomical properties of the liver parenchyma in the NIR wavelength range 
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(630-1000 nm)[8]. The primary goal of this thesis is to assess the ability of the opto-
fluidic phantoms developed by Ruiqi Long et al. to mimic the flow properties of the 
portal vein and liver parenchyma. To evaluate how effectively the phantoms mimic the 
flow properties of liver parenchyma, in vitro perfusion studies must be performed with 
the phantoms and the prototype sensor. The data gathered during the in vitro studies will 
be compared to data acquired from in vivo pig studies. A secondary goal of this thesis is 
to study the effects of varying oxygenation on the sensor performance. Data will be 
acquired during in vitro studies on the parenchymal phantoms. To fulfill the goals of this 
research, the following specific aims are proposed: 
 Specific Aim 1: Complete flow system for in vitro parenchymal and portal 
vein phantoms. 
     We will develop a flow system along with a dye solution that mimics the 
absorptive properties of hemoglobin to incorporate pulsatile flow through a 
phantom that mimics the optical and anatomical properties of the liver for use in 
preliminary studies. Studies will be conducted on phantoms that mimic the 
optical and anatomical properties of both the liver parenchyma and portal vein.  
 Specific Aim 2: Compare flow characteristics of the parenchymal and portal 
vein phantoms to in vivo porcine parenchyma flow characteristics. 
In this work, the ability of the parenchymal and portal vein phantoms to mimic 
the flow properties of the liver will be assessed. The measured signal from the 
phantoms will be compared with the signal measured from porcine liver. 
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In the following work, the ability of phantoms developed by Long et al to mimic 
the flow properties of the portal vein and of liver parenchyma will be assessed. Overall, 
it was shown that the phantoms effectively mimic the flow properties of liver 
parenchyma. Specifically, both the single and multilayer parenchymal phantom showed 
similar responses to changes in perfusion. However, the multilayer phantom had a 
greater sensitivity to changes in perfusion a higher signal. Therefore, while both 
parenchymal phantoms can be used to facilitate sensor design, it is more applicable to 
use the multilayer phantom because it more closely mimics the anatomical properties of 
liver parenchyma. The portal vein phantom also showed a similar response to in vivo 
perfusion studies. It was concluded in this work that the phantoms mimicking the liver 
parenchyma and the portal vein can be used to facilitate sensor design. 
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CHAPTER II  
BACKGROUND 
The first section of this chapter covers the anatomy of hemoglobin, the 
physiology of oxygen transport, and the anatomy and physiology of the liver. The next 
section covers current methods employed to monitor tissue perfusion followed by a 
section on pulse oximetry—it’s history, limitations, and implementation in the clinical 
setting.  
2.1 Anatomy and physiology 
2.1.1 Oxygen transport 
Oxygen is one of the most essential elements for the human body. It is 
responsible for maintaining the proper functioning of each cell in the body, and most 
importantly, it is essential for the respiratory process, which is the basis for how we use 
stored energy. Oxygen is transported to the cells of the body through hemoglobin, a 
molecule present in red blood cells. This phenomenon makes hemoglobin one of the 
most essential molecules in the human body. The oxygen transport process begins with 
the breathing of air into the lungs. Blood passing through the lungs is oxygenated by the 
air that is breathed into the lungs and is transported to various parts of the body. The 
cells of the body use the oxygen present in the hemoglobin, and the resultant 
deoxygenated blood is returned to the lungs to be oxygenated once again. The lungs 
serve to allow the exchange of gases in the blood resulting in the blood ridding itself of 
carbon dioxide (a byproduct of respiration) and replenishing itself with oxygen. The 
oxygenated blood is then recirculated throughout the body [9, 10]. 
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Hemoglobin is the most important molecule present in red blood cells because it 
allows oxygen to be transported to the cells of the body. A hemoglobin molecule is a 
protein that consists of four heme groups each bound to a polypeptide chain. Each of the 
heme groups in a hemoglobin molecule contains an atom of iron that allows an oxygen 
molecule to bind to the heme group. Therefore, a single hemoglobin molecule can bind 
four oxygen molecules. The polypeptide chains bound to each of the four heme groups 
are collectively called a globin [9, 10]. Hemoglobin exists in many forms, but the two 
most prevalent forms in the bloodstream are oxygenated (HbO2) and deoxygenated (Hb) 
hemoglobin. Oxygenated hemoglobin is reddish in color and absorbs more light in the 
near infrared (NIR) wavelength range than in the red and far red wavelength range. In 
contrast, deoxygenated hemoglobin is bluish in color and absorbs more light in the red 
and far red wavelength range than in the NIR wavelength range. This absorption 
difference is exploited in pulse oximetry, which is a clinically accepted method to non-
invasively measure arterial oxygen saturation [11, 12]. The partial pressure of oxygen 
(PO2) is directly related to the amount of oxygen dissolved in the blood. Some oxygen 
may be present in the blood plasma, but this oxygen content only represents 
approximately 3% of the total oxygen supplied to the cells by the blood. The remaining 
97% of oxygen present in the blood is bound to hemoglobin molecules, and a measure of 
the ratio of the amount of oxygen bound to the hemoglobin to the oxygen carrying 
capacity of the hemoglobin is known as oxygen saturation (SO2) [9, 10]. Since a 
majority of the oxygen is transported by hemoglobin molecules, measures of the amount 
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of blood supplied to various parts of the body as well as the oxygenation of the blood 
being transported are important in assessing the health of a patient.  
2.1.2 Liver anatomy and physiology 
The liver is an essential organ in the body, and its most important functions lie 
within three categories: metabolic functions, secretory and excretory functions, and 
vascular functions. The vascular function is responsible for the storage and filtration of 
blood, and this research project focuses on the vascular function of the liver. The liver 
receives blood from two sources, the hepatic artery and the portal vein. The hepatic 
artery supplies oxygenated blood at a rate of 350 mL/min (~25% of the total blood 
volume), and the portal vein supplies venous blood at a rate of 1100 mL/min (~75% of 
the total blood volume). Blood flow through the liver averages about 1450 mL/min, 
which is approximately 29% of the cardiac output of a resting adult. The liver can also 
serve as a blood reservoir capable of storing an additional 0.5 to 1 liter of blood when 
high pressure in the right atrium of the heart causes back pressure in the liver—a 
common symptom of congestive heart failure [9, 10, 13]. 
The basic functional unit of the liver is a structure known as the liver lobule. A 
liver lobule is hexagonally structured, several millimeters in depth, and ranges from 0.8 
to 2 millimeters in diameter. The length of each side of the liver lobule ranges from 0.5 
to 1 millimeter. The average liver consists of roughly 1 million liver lobules, and each 
liver lobule consists of portal triads, sinusoids, hepatocytes, and the central vein. The 
portal triads (a total of six per lobule) are located at the point where two edges of the 
hexagonally structured liver lobules meet, and each triad consists of branches of the 
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portal vein, hepatic artery, and bile canaliculi. The sinusoids are small channels lined 
with hepatocytes that allow blood to drain from the portal triads into the central vein. It 
is within these channels of the sinusoids that the exchange of oxygen and other nutrients 
takes place. Located at the center of the liver lobule is a branch of the central vein, which 
empties into the hepatic vein. The hepatic vein empties into the superior vena cava 
where the blood mixes with other venous blood from the periphery of the body [9, 10, 
13]. The primary goal of this research project is to assess the effectiveness of liver 
phantoms developed by Long et al. [8] in mimicking the flow properties of actual liver 
tissue. 
2.2 Current monitoring methods 
Current monitoring methods include Laser Doppler Flowmetry, Thermal 
Diffusion, Computed Tomography (CT), Diffuse Correlation Spectroscopy (DCS), 
Diffuse Reflectance Spectroscopy (DRS), Magnetic Resonance Imaging (MRI), and 
Near Infrared Spectroscopy (NIRS) with Indocyanine Green (ICG) as a contrast agent 
[14-45]. Laser Doppler Flowmetry measures perfusion by correlating the Doppler Shift 
induced by moving objects to blood flow. However, this technique is susceptible to high 
motion artifact making it not suitable for implantation [15]. Thermal Diffusion is a 
technique that measures local tissue perfusion based on thermal convection. A typical 
thermal diffusion probe consists of a proximal and a distal thermistor. The proximal 
thermistor measures the baseline temperature of the surrounding tissue, and the distal 
thermistor is powered to induce a slight temperature increase in the local tissue volume. 
The power required to maintain this increase in temperature is a function of blood 
 9 
perfusion within the tissue volume [46, 47]. Although this technique is capable of 
measuring perfusion in localized tissue, it is difficult to apply directly to blood vessels, 
which would be useful in monitoring graft health. Indocyanine Green is a dye with a 
characteristic absorption peak near the hemoglobin isobestic point (805 nm). It’s 
clearance from the plasma by liver tissue is measured by Near Infrared Spectroscopy 
(NIRS), and its plasma concentration vs. time can be used to predict perfusion in the 
liver [48]. A problem with the aforementioned techniques is the lack of provision of 
oxygenation information which is essential information when assessing the health of a 
graft and of the liver tissue. DCS and DRS are often combined to simultaneously 
measure blood perfusion and oxygenation. DCS measures the decay rate of an electric 
field autocorrelation function generated when light is multiply scattered from turbid 
media, such as blood, and correlates this decay rate to the flow rate of the blood. While 
the DCS and DRS devices are capable of measuring blood perfusion and oxygenation, 
the devices have not been sufficiently miniaturized for implantation [30, 34, 49]. CT and 
MRI, while capable of measuring blood perfusion, involve the use of a contrast agent to 
measure flow, are not feasible for implantation, and do not provide information on 
oxygenation. While the aforementioned methods are capable of monitoring blood 
perfusion in the liver under normal and adverse conditions (i.e. cirrhosis, partial, and 
total vessel occlusion), due to size, cost, need for a contrast agent, and/or lack of 
oxygenation information, they are not suitable for implantation and for continuous, real-
time monitoring of perfusion over a two-week period.  
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2.3 Pulse oximetry 
Optical-based monitoring techniques provide a means to monitor blood perfusion 
and oxygenation in a minimally invasive manner. One specific method that has been 
clinically accepted as a means for monitoring tissue oxygenation is pulse oximetry. 
Throughout the past two decades, pulse oximetry has become increasingly used to 
monitor tissue oxygenation in the clinical setting [11, 50-66].  
2.2.1 History of pulse oximeters 
The first documented use of light to measure blood oxygenation dates back to the 
late 1800’s where the reduction of red light transmitted or reflected through the tissue of 
a hand was recorded by a physicist named Karl von Vierordt in 1874 [63]. The first 
oximeter was invented during World War II by a physiologist named Glenn Allen 
Milikan. Initially invented as a means to measure the arterial oxygen saturation of pilots, 
the first oximeters were heavy, cumbersome to transport, required extensive calibration 
before each use, and were limited to use on the earlobe. Also, the Milikan invention did 
not take into account the presence of other light-absorbing species in the earlobe. 
Therefore, calibration of his device required the earlobe to be cuffed and rendered 
bloodless to obtain the background signal due the presence of additional absorbers such 
as skin, cartilage, and other tissues. Also, to eliminate the absorption due to venous 
blood, the earlobe was heated to 44
o
 C, and a measurement was taken on a hyperemic 
ear that consisted of arterial blood only [67]. Two significant improvements to the 
oximeter were made in the 1970’s that drastically improved the accuracy and portability 
of the device. The first improvement was made by Hewlett-Packard Corporation and 
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featured the use of multiple wavelengths of light to measure oxygenation [67]. The 
“pulse oximeter” was discovered by Takuo Aoyagi in the mid 1970’s. He noticed that 
dyes injected into the blood stream showed a pulsatile absorption and that the amplitude 
of the pulsations was dependent on the arterial oxygen saturation of the patient [63]. 
With the invention of the pulse oximeter, the need for extensive calibration, such as in 
the Milikan case, was eliminated. However, as with the Milikan invention, this device 
was limited to use on the earlobe and was therefore cumbersome to use. The second 
improvement was made by an engineer named Scott Wilber, who used solid state light 
emitting diodes (LEDs) as the light source and a photodiode as the detector [67]. This 
improvement reduced the size of the device and increased its portability. Currently, 
pulse oximeters are clinically accepted as a means for non-invasively measuring arterial 
oxygen saturation [11, 12, 50]. 
2.2.2 Principle of pulse oximetry 
Oximetry is a technique that utilizes the absorption difference between Hb and 
HbO2 in the far red and near infrared (NIR) wavelength range. Light within the 600-
1000 nm wavelength range is capable of penetrating fairly deeply into tissue. Due to the 
optical properties of tissue within this wavelength range, the reflectively of light within 
the 600-1000 nm wavelength range can be used to measure the perfusion and 
oxygenation of blood within the tissue volume being probed. Oximetry utilizes the 
technique of measuring the reflectivity or transmission (based on the differences in the 
absorption of Hb and HbO2) of light through tissue and correlating the measured 
reflectivity or transmission to tissue oxygenation.  
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Pulse oximetry utilizes the same principles as oximetry in conjunction with a 
unique feature of the circulatory system—the pulsatile signal generated by arterial blood. 
The pulsatile signal generated by the arterial blood is relatively independent of tissue, 
venous blood, capillary blood, and non-pulsatile arterial blood. As arterial blood is 
pulsed through the body, the absorption of light in the far red and NIR wavelength 
ranges increases and decreases with each cardiac cycle. The increase and decrease in the 
absorption with each cardiac cycle generates an alternating current (AC) signal that is 
used to calculate the oxygenation of the arterial blood. Traditional pulse oximeters used 
LEDs that emitted at 660 nm (red) and 940 nm (infrared) due to the absorption 
properties of Hb and HbO2 at these two wavelengths (Figure 1). The ratio of absorbances 
at these two wavelengths is used to form a calibration curve that is used to estimate the 
SaO2 of the patient. The ratio, R (Equation 1), is calibrated empirically against a direct 
measurement of SaO2 from volunteers. The algorithm derived from this empirical 
calibration is used in the signal processing of the pulse oximeter to estimate the patient’s 
oxygen saturation. 
    
Absorbance ed
AbsorbanceI 
 (1)  
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Figure 1: Extinction coefficients of Hb and HbO2 [68]. 
 
 
 
 
The measurement technique of pulse oximeters is based on the Beer-Lambert 
Law, which relates the intensity of light transmitted through a material to the optical 
properties (particularly the absorption and scattering) of the material. In the case of a 
liquid, the Beer-Lambert Law relates the intensity of light transmitted through the 
solution to the concentration of solute present in the solution. For liquids, the Beer-
Lambert Law can be written as 
 I  I0e
  CL (2)  
where I and I0 represent the intensity of the transmitted and incident light, respectively.   
(mmol∙L-1∙cm-1) is the wavelength-dependent molar extinction coefficient, C  (mmol∙L-1) 
is the concentration of the solute, and L (cm) is the path length of the light through the 
solution [69]. Assuming that the material is not a highly scattering medium,   can 
represent the absorption of the material. However, for highly scattering mediums,   is a 
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function of the absorption, µa (cm
-1
), and scattering, µs (cm
-1
), properties of the material. 
It must be noted that the Beer-Lambert Law assumes that the sum of the transmitted and 
absorbed light is equal to the incident light. It does not account for light that is reflected 
at the surface of the medium. 
Early oximeters used tissue as the “cuvette” containing the hemoglobin for 
measurement of its absorption properties (Figure 2). However, tissue contains many 
other absorbers in addition to arterial blood, such as melanin, venous and capillary 
blood, and bone.  Pulse oximeters are capable of distinguishing between pulsatile arterial 
blood and other absorbers by utilizing the pulsatile nature of arterial blood. Arterial 
blood pulses through the body as a result of the expansion of the arteriolar bed during 
systole, and this measured pulsatile signal can be viewed as an AC signal. The 
absorbance from materials other than pulsatile arterial blood is constant, and can be 
viewed as a direct current (DC) signal.  
 
 
 
 
 
Figure 2: Transmission (left) and reflectance (right) pulse oximetry. 
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The increase in arteriolar volume during systole causes an increase in the optical 
path length of the light and results in an increase in the absorption. It must be noted that 
the technique of pulse oximetry makes a critical assumption—that all pulsatile 
absorbance is due to pulsatile arterial blood. Any other sources of pulsatile absorbance 
will result in an error in the measurement of arterial oxygen saturation. The height of the 
AC signal at the red and infrared wavelengths varies as a function of oxygenation 
(Figure 3). 
The variance in the AC signal as a function of oxygenation is due to the 
difference in the absorption properties of Hb and HbO2 at these wavelengths. Therefore, 
the ratio, R, can be rewritten as follows 
    
AC ed
DC ed
 
ACI 
DCI 
 
 (3)  
This ratio is related to hemoglobin oxygen saturation (SaO2). The oxygen saturation 
measured by the pulse oximeter (SpO2) is derived from the calibration curve that relates 
R to arterial oxygen saturation.  Figure 4 shows a theoretical calibration curve for a 
typical pulse oximeter. The SaO2 is a function of R, and can be written as follows: 
   aO2( )   
 Hb       Hb  I   
 Hb       HbO2        HbO2  I     Hb  I    
x 100   (4)  
where  Hb( R) and  HbO2( R) are the extinction coefficients of Hb and HbO2, respectively, 
at the red wavelength, and  Hb( IR) and  HbO2( IR) are  the extinction coefficients of Hb 
and HbO2, respectively, at the infrared wavelength.  
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Figure 3: Sinulated red (660 nm) and infrared (940 nm) AC signals at different arterial 
oxygen saturations
1
. 
  
                                                 
1 Simulation performed with MatLAB (Mathworks, Inc.) 
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Figure 4: Typical calibration curve for a pulse oximeter. 
 
 
 
 
2.2.3 Clinical applications of pulse oximeters 
Pulse oximeters are useful, non-invasive tools used to monitor the arterial oxygen 
saturation, heart rate, and blood perfusion of patients in the clinical setting. One of the 
more common uses for pulse oximetry is arterial oxygen saturation monitoring during 
the administration of general anesthesia. In this setting, the pulse oximeter is valuable 
because it is capable of rapidly detecting hypoxia (SaO2 < 90%) and alerting the 
anesthesiologist so that oxygen can be administered in a timely manner. Among other 
uses of pulse oximeters are fetal oxygenation monitoring, monitoring of arterial oxygen 
saturation during sleep apnea, and monitoring of arterial oxygen saturation of patients 
being transported from the operating room to the recovery room [58, 59, 65, 70].  
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2.2.4 Limitations of pulse oximeters 
Low oxygen saturation, motion artifact, low perfusion, and the presence of other 
species of hemoglobin are a few factors that may result in an inaccurate reading in pulse 
oximetry [67]. Pulse oximeters are designed to distinguish between two species of 
hemoglobin, HbO2 and Hb, by employing two wavelengths of light. Pulse oximeters 
work well when HbO2 and Hb are the only absorbing species of hemoglobin in the 
blood. However, the presence of alternative absorbing species of hemoglobin, mainly 
carboxyhemoglobin (COHb) and methoxyhemoglobin (MetHb), cause pulse oximeters 
to display incorrect oxygen saturation information. COHb, due to its absorption 
properties is seen as additional HbO2 by pulse oximeters. MetHb is seen as both Hb and 
HbO2 due to its aborbance in both the red and infrared wavelength range. The presence 
of a substantial amount of MetHb results in a false oxygen saturation value of 85% [67]. 
One technique that can be employed to eliminate the effects of COHb and MetHb is the 
use of additional wavelengths of light to distinguish between the different species of 
hemoglobin. The use of additional wavelengths of light provides the device with an 
independent measurement of the other species so that their absorbance can be subtracted 
from the Hb and HbO2 absorbances. However, this adds to the complexity of the device 
[51]. 
Motion artifact is a significant source of error in pulse oximeters. The presence 
of motion artifact can either obscure the true photoplethysmographic signal or cause the 
device to interpret the motion artifact as the true photoplethysmographic signal. Another 
effect of motion artifact is a decrease in signal-to-noise ratio [71]. The misinterpretation 
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of data resulting from motion artifact can lead to inaccurate readings, false alarms, and 
missed true alarms. Various methods have been employed to combat the effects of 
motion artifact in pulse oximetry, but have resulted in little success [71, 72].  
Developing an implantable sensor that utilizes light within the 600-1000 nm 
wavelength range provides a minimally invasive way to continuously monitor blood 
perfusion and oxygenation of an implanted organ. Issues with biocompatibility that often 
arise with implanted devices and sensors can be bypassed by coating the sensor in a 
biocompatible, optically transparent material. Development of such a sensor system 
would aid in reducing the amount of failed transplant procedures and should aid in 
decreasing the amount patients on the waiting list for organ transplants. 
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CHAPTER III  
MATERIALS AND METHODS 
The first section of this chapter provides a brief description of the sensor system 
design. The second section provides a description of the in vitro system setup used to 
perform experiments on the portal vein phantom and single layer and multilayer 
parenchymal phantoms, and the final section provides a description of the in vivo setup 
used for animal studies. 
3.1 Sensor system design 
The sensor system used during the in vitro experiments features a custom probe 
design used to measure oxygenation and perfusion of an organ by measuring 
backscattered light intensity. The sensor system delivers three wavelengths of light (735 
nm, 805 nm, and 940 nm) via a three-LED light source (Epitex, L660/735/805/940-
40B42-C-I), and the backscattered light is detectetd with a silicon photodetector 
(Hamamatsu, S2833-01). The three wavelengths of light emitted by the light source 
exploit the wavelength-dependent absorption of Hb and HbO2 to extract oxygenation and 
perfusion information. A spherical glass lens is placed over the light source so that each 
of the wavelengths of light is directed onto the same tissue volume. The three-
wavelength source is multiplexed in time and modulated via a unit developed by Oak 
Ridge National Laboratories (ORNL) to minimize power consumption and to eliminate 
background noise measured by the photodetector from ancillary light sources. The unit 
contains four anterior input channels, allowing for the detection of four signals with four 
separate probes, and eight posterior analog BNC inputs for detection of signals collected 
 21 
from external sources. The analog BNC inputs provide a convenient interface for 
collecting time-correlated data from additional instruments such as Laser Doppler flow 
meters or thermal dilution monitors while gathering perfusion and oxygenation data. 
Several source-detector spacings for the probes (2 mm, 4 mm, 6 mm, 8 mm, and 10 mm) 
were available for use with the in vitro experiments.  
The probe head is tethered to a box containing the power supply and the circuitry 
for modulation of the source light and demodulation of the detected signal. The circuitry 
consists of a demodulation circuit and a series of analog filters to separate the AC 
portion of the measured signal from the direct current (DC) portion. The analog output 
of the sensor electronics is input into a National Instruments data acquisition module 
(National Instruments; USB 6255) where it is then transferred to LabVIEW software 
(National Instruments) via a USB cable. A LabVIEW data acquisition program was 
written by ORNL to collect, display, and store the data in real time. The LabVIEW 
program provides the user with the ability to monitor the status of the four analog input 
channels as well as the external channels simultaneously or to monitor the status of an 
individual channel in more detail. Data sent to the LabVIEW program is stored in a text 
document for future analysis. 
3.2 In vitro system setup 
To assess the optical coupling and compliance of the phantom and to gather 
perfusion and oxygenation data, an in vitro system was setup for the single and 
multilayer parenchymal phantoms as well as the portal vein phantoms. The parenchymal 
phantoms were designed to imitate the case where the probe is placed on the surface of 
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the liver, and the portal vein phantoms were designed to imitate the case where the probe 
is placed on the portal vein just as it enters the liver.  
3.2.1 Phantom design 
The Polydimethylsiloxane (PDMS) based portal vein phantoms were prepared by 
mixing 437.4 mg of 0.5-1 µm Al2O3 powder (99.99% purity, Inframat ® Advanced 
Materials
TM
), 120 mg of 100 nm Al2O3 powder (99.99% purity Inframat ® Advanced 
Materials
TM
), 4.01 µL of black India Ink (Higgins, Black India 4415), 120 µL of blue 
food coloring (Wilton ®), and 60 mL of PDMS resin (SYLGARD ® USA). Long et al. 
has shown the ability of this mixture to mimic the optical properties of liver tissue in the 
far red and near infrared (NIR) wavelength range[8]. The mixture was sonicated and 
stirred until homogenous, and 6 mL of curing agent was added at a volumetric ratio of 
1:10. The mixture containing the curing agent was stirred and cast into a plastic mold 
(Petri Dish approximately 40 mm in diameter). For the portal vein phantoms, a rigid 
plastic tube approximately 8 mm in diameter was inserted into the mold. A vacuum was 
applied to remove any bubbles that may have been present in the mixture, and then the 
mixture was allowed to cure for 2 hours in an oven at 65
o
C to crosslink the PDMS. After 
the mixture cured, the rigid plastic tube was removed, and a compliant portal vein 
phantom resulted. For the non-compliant portal vein phantom, the rigid plastic tube was 
allowed to remain in the mold after the PDMS mixture cured. Figure 5 displays a front 
and side view of the PDMS based portal vein phantom and multi-layer parenchymal 
phantom. 
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Figure 5: Schematic of the PDMS based compliant portal vein phantom showing the 
probe placed on top and a schematic of the multi-layer parenchymal phantom showing 
the design of the sinusoid layers and their location within the PDMS. 
 
 
 
 
For the parenchymal phantoms, the same mixture used to construct the portal 
vein phantoms was employed. However, instead of containing a tube through the center, 
the phantoms contain microfluidic channels mimicking the liver sinusoids. A two-
dimensional pattern of micro-fluidic channels mimicking the hexagonal sinusoids was 
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designed with computer-aided design (CAD) software (Rhinoceros 4.0). The design for 
the single layer parenchymal phantom consisted of one layer of sinusoids, and the design 
for the multi-layer parenchymal phantom consisted of three layers of sinusoids. The 
channels were cast into the PDMS mold using soft lithography. The PDMS mixture on 
the micro-patterned mold was degassed to remove any bubbles present between the 
channels. Holes were drilled through the thicker underside of the phantom in such a 
manner that they terminated at the ports of the microfluidic channels, and flat-tipped 20-
guage needles (VWR, cat. # KT868280-2001) were inserted into the ports to allow dyes 
mimicking the absorbance of oxygenated and deoxygenated hemlglobin at our 
wavelengths of interest to be pulsed through the microfluidic channels. The width and 
height of the microfluidic channels are 15 µm and 50 µm, respectively.  
3.2.2 Dyes mimicking hemoglobin absorption properties 
To avoid handling whole blood, which needs to be placed in a temperature and 
pH-controlled environment and requires oxygenation and monitoring of the oxygenation, 
two dye solutions were formulated to mimic the absorption properties of Hb and HbO2 at 
our wavelengths of interest [68, 73-75]. To mimic the absorption of hemoglobin in its 
oxygenated state, 0.088 % v/v India Ink (Higgins, Black India 44120) and 0.304 mg/mL 
Epolight 2717
TM
 (Epolin, Inc.) were mixed in a Phosphate Buffered Solution (PBS 
0.01M, pH 7.4). The India Ink is used as a baseline because it has an extinction 
coefficient that covers all of our wavelengths of interest, and the Epolight 2717
TM
 is used 
to increase the absorption in the NIR region [76, 77]. To mimic the absorbance of 
hemoglobin in its deoxygenated state, 0.165% v/v India Ink and 2.67% v/v Ink Jet Photo 
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Cyan (Macro Enter, cat. # FPB085) were mixed in PBS. The absorption coefficients of 
the two dye solutions compared to that of Hb and HbO2 along with the output spectrum 
of the LED source are shown in Figure 6. 
 
 
 
 
Figure 6: Comparison of the absorption spectrum of HbO2 (solid red line) and Hb (solid 
blue line) and the dye solutions mimicking the absorption properties of Hb (dashed blue 
line) and HbO2 (dashed red line) (a) and the normalized output power of each 
wavelength of the LED (b). 
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Figure 6: Continued. 
 
 
 
 
To avoid clogging the microfluidic channels of the parenchymal phantoms, the 
India Ink was filtered through 0.45 µm syringe filters. India Ink was mixed in PBS at a 
concentration of 0.88% v/v for the oxygenated solution and 1.65% v/v for the 
deoxygenated solution and filtered through the syringe filters. After the India Ink 
mixture was filtered through the 0.45 µm syringe filter (VWR, cat. # 28145-481), the 
absorption spectra of the filtered solutions were measured. After measuring the 
absorption spectra, Epolight 2717
TM
 and Ink Jet Photo Cyan were then added to the dye 
solutions mimicking HbO2 and Hb, respectively. 
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3.2.3 Flow system setup 
To achieve pulsatile flow, which is characteristic of the flow in the liver and the 
vessels leading to the liver, peristaltic pumps (Gilson, Minipuls 3) were used. To achieve 
volumetric flow rates in the portal vein phantoms that are within the physiologic range 
for the portal vein, two peristaltic pumps were used (Figure 7). For the single and 
multilayer parenchymal phantoms, only one peristaltic pump was used (Figure 8). In 
both instances, the pumps were driven via a data acquisition board (National 
Instruments, USB 6009) and a custom program developed using LabVIEW. The driver 
signal for the peristaltic pumps was a square wave, and the pump frequency and pulse 
width were set to the desired values to mimic the pulsatile flow pattern of the liver 
parenchyma and portal vein. For the in vitro experiments, the pump frequency was set to 
100 pulses per minute to match the in vivo porcine data. For the perfusion experiments, 
the pulse height of the pumps was varied to mimic volumetric flow rate variations within 
the physiologic range of the liver.  
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Figure 7: Block diagram of the in vitro setup used for the portal vein phantom. 
 
 
 
Figure 8: Block diagram of the in vitro setup used for the parenchymal phantoms. 
 
 
 
 
Loading of the parenchymal phantoms with the dye solutions required a slight 
modification of the procedure used for the portal vein phantoms. This modification came 
in the form of using two syringe pumps to load the phantoms with the dye solutions. The 
first syringe pump (Harvard Apparatus, cat. # 70-2208) was connected to the input ports 
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and set to pump at a volumetric flow rate of 0.3 mL/min and 0.9 mL/min for the single 
and multilayer phantom, respectively, and the second syringe pump (New Era Pump 
Systems, Inc., NE-4000) was connected to the output ports and set to withdraw at a rate 
of 0.35 mL/min and 0.95 mL/min for the single and multilayer phantom, respectively. 
This syringe pump configuration was used to prevent the connections between the 
needles and the ports from bursting under the pressure of the fluid. The second pump 
was set to withdraw at a higher volumetric flow rate than the first pump was pumping to 
establish a negative pressure gradient within the microfluidic channels to further aid in 
preventing the connections from bursting. 
3.2.4 Data collection 
In order to assess the ability of the phantoms to mimic the in vivo case regarding 
oxygenation and perfusion, two sets of experiments were performed. The first set of 
experiments involved pulsing a dye solution mimicking the absorption properties of 
100% oxygenated hemoglobin through each of the phantoms and varying the volumetric 
flow rate of the dye solutions. The second set of experiments involved keeping the 
perfusion constant while varying the concentrations of the dyes to mimic different 
oxygenation states of blood. Dyes mimicking 0%, 30%, and 50-100% oxygenation were 
pulsed through the parenchymal phantoms. 
In vivo data was collected from the portal vein and liver parenchyma of female 
swine to determine the effectiveness of the phantoms to mimic the physiologic flow 
properties of actual portal vein and liver parenchyma. The data was collected from 
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probes placed on the female swine’s liver parenchyma and portal vein. This procedure 
was performed under an approved protocol and will be further described in Section 3.3. 
To assess optical coupling of the phantom, initial perfusion experiments on the 
single layer parenchymal phantom were conducted with and without the use of optical 
coupling gel. A small amount of optical coupling gel (Thorlabs; part # G608N) was 
placed on the surface of the 3-LED light source and on the silicon photodetector to 
eliminate any air gaps present between the LED surface, silicon photodtector surface, 
and the phantom surface. The same procedure was performed for the multilayer 
parenchymal phantom. 
To assess the effect of material compliance, experiments were conducted on the 
portal vein phantom containing a rigid plastic tube in the center and on the portal vein 
phantom consisting of a hollow tube through the center. The pulse rate of the peristaltic 
pump was set at 100 pulses per minute, and the AC and DC signals were acquired with 
the sensor system. A Fast Fourier Transform (FFT) was performed on the AC signals 
acquired from both phantoms, and the FFT peak presence, location, and height were 
evaluated. For each experiment, the same setup described in Section 3.2.3 was used. 
3.3 In vivo system setup 
3.3.1 In vivo occlusion studies 
For approximately 15 minutes prior to induction with anesthesia a female swine 
was premedicated with Telazol (5-10 mg/kg) and Buprenorphine (0.01-0.05 mg/kg) 
intramuscularly (IM). Anesthesia was induced by administering isoflurane (~3-4%) in 
oxygen at a rate of 3L/min via a face mask. An appropriately sized endotracheal tube 
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was used to intubate the swine according to the approved animal use protocol. 
Maintenance of anesthesia was achieved with Isoflurane (0.5-4%) in Oxygen (15 mL/lb, 
maximum 5L). The swine’s  pO2 was monitored by a pulse oximetry probe placed on 
the swine’s ear. To allow venous access, a catheter (~18-20 g) was inserted and secured 
in the auricular vein. Mechanical respiration was provided at a rate of 8-12 breaths per 
minute (BPM) and tidal volume of 5-10 mL/lb via a ventilator. 
A laparotomy was performed to gain access to the liver parenchyma, portal vein, 
and hepatic artery, and the custom prototype probes were stitched onto the left and right 
lobe of the liver, on the hepatic artery, and on the portal vein. Mechanical vessel 
occluders were secured around the hepatic artery and portal vein to perform the vessel 
occlusion studies. Before occlusion of each vessel, at least one 60 second segment of 
data was collected to establish a baseline. The data set for the in vivo study consisted of 
24, 60 second segments. Each segment was analyzed using FFT analysis. 
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CHAPTER IV  
RESULTS AND DISCUSSION 
The first section of this chapter presents the results of a compliance assessment 
performed on the portal vein phantoms. The second section of this chapter presents a 
study performed on the coupling effectiveness of the PDMS-based phantoms. The next 
section of this chapter contains a comparison of the in vitro data gathered from perfusion 
studies on the phantoms to in vivo data collected while performing vascular occlusion 
studies on a female swine. The final section of this chapter presents oxygenation studies 
performed on the phantoms. 
4.1 Phantom compliance 
Figure 9 displays a 10-second segment of the time-domain AC signal measured 
with the noncompliant (a) portal vein phantom along with the corresponding Fast 
Fourier Transform (FFT) of the entire 60-second data segment (b) in comparison to a 10-
second segment of the time-domain AC signal measured with the compliant portal vein 
phantom (c) and the corresponding FFT of the 60-second data segment (d). Also 
pictured is a 10-second segment of the time-domain AC signal taken from the porcine 
portal vein (e) and the corresponding FFT of the complete 60-second data set (f). For 
each in vitro experiment, the probe LED and photodetector were placed directly on top 
of the phantom and in line with the tube that allowed the dye solutions to be pulsed 
through the phantoms.  
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Figure 9: 10-second data segments of the time-domain AC signal measured on the non-
compliant (a) and compliant (c) portal vein phantoms as well as the pig portal vein (e) 
along with the corresponding FFT spectra of 60-second data segments of the time-
domain AC signal gathered with the non-compliant (b) and compliant (d) portal vein 
phantoms as well as the pig portal vein (f). 
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The non-compliant phantom was incapable of producing an AC signal, as was 
expected due to the presence of a rigid (non-compliant) tube through the center of the 
phantom. The FFT spectrum of the data gathered from the non-compliant phantom 
shows a peak at the frequency (1.667Hz) that corresponds to the pump pulse rate (100 
bpm). However, with the compliant portal vein phantom, an AC signal was produced 
resulting in an FFT spectrum containing a peak at 1.667 Hz that was an order of 
magnitude higher than the peak at 1.667 Hz measured with the non-compliant portal 
vein phantom. Also, the time-domain AC signal of the compliant portal vein phantom 
more closely mimics the time-domain AC signal of the in vivo data set (Figure 9e, 9f). 
As a result of this observation, ensuing in vitro experiments regarding the portal vein 
were performed on the compliant portal vein phantom. Note that the ratio of the second 
harmonic peak to the first harmonic peak in the FFT spectrum of data taken from the 
non-compliant phantom is larger than the ratio of the second harmonic peak to the first 
harmonic peak in the FFT spectrum of data taken from the compliant phantom and from 
the actual portal vein of the pig. The ratio of the second harmonic peak to the first 
harmonic peak is lowest in the FFT spectrum of the actual portal vein data. Further 
studies must be done to determine if this ratio is a function of the compliance of the 
vessel. 
4.2 Optical coupling 
To maximize the signal measured by the sensor system, it is important to 
maximize the amount of light that reaches the photodetector or minimize the amount of 
light lost at the interface of the photodetector and phantom surface due to the difference 
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in the index of refraction of the glass coating the photodetector (n = 1.4), air (n = 1.33), 
and PDMS (wavelength dependent; n735 = 1.4089, n805 = 1.4076, and n940 = 1.4056). 
Experiments on the single layer parenchymal phantom were performed with and without 
coating the surface of the sensor with optical coupling gel for comparison. Figure 10 
displays a comparison of the FFT of the time-domain AC signals measured with (a) and 
without (b) the use of optical coupling gel. 
 
 
   
 
Figure 10: 10-second segment of the time domain AC signal measured from the single 
layer parenchymal phantom without (a) and with (b) optical coupling gel. 
 
 
 
 
It can be seen that with the use of optical coupling gel, the magnitude of the peak 
in the FFT spectrum at 1.67 Hz is greater than the magnitude of the peak in the FFT 
spectrum of the signal collected without the use of optical coupling gel. Also, the DC 
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the use of optical coupling gel (Table 1), indicating that more light is collected by the 
photodetector. As a result of this observation, optical coupling gel was used for all in 
vitro perfusion and oxygenation experiments. 
 
 
 
Table 1: DC voltages measured with and without the use of optical coupling gel. 
Wavelength 735 nm 805 nm 940 nm 
Single Layer Parenchymal Phantom 
    DC signal: No optical coupling gel 1.249 V 1.914 V 1.181 V 
    DC signal: Optical coupling gel 1.699 V 2.565 V 1.622 V 
Compliant Portal Vein Phantom 
    DC signal: No optical coupling gel 1.174 V 1.75 V 1.333 V 
    DC signal: Optical coupling gel 1.397 V 2.083 V 1.602 V 
 
 
4.3 Perfusion studies 
To assess how well the phantoms mimicked the flow properties of liver 
parenchyma and of the portal vein, perfusion studies were performed on the single layer, 
multilayer, and portal vein phantoms, and the data collected was compared to in vivo 
data collected from vessel occlusion studies performed on female swine. For the single 
and multilayer phantoms, the comparison was performed to assess the ability of the 
phantoms to mimic the physiologic response of perfused liver parenchyma. 
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4.3.1 In vitro perfusion studies 
To simulate a decrease in perfusion of blood entering the liver parenchyma, the 
peristaltic pump was set to pump at different levels that corresponded to a specific 
volumetric flow rate of the dye solutions. As blood enters the liver parenchyma, light at 
our wavelengths of interst (735, 805, and 940 nm) is absorbed by the hemoglobin 
present in the blood. While the absorption coefficients at the 735 nm and 940 nm 
wavelengths vary with oxygenation, the absorption at all three wavelengths varies with 
perfusion (assuming oxygenation is held constant). Higher levels of perfusion result in 
an increase in the amount of blood being pulsed through the vessels and organs. As more 
blood is pulsed through the volume of tissue, the difference in the amount of blood 
present during systole and diastole is greater and translates into more light being 
absorbed with each pulse. Therefore, an increase or decrease in perfusion should result 
in an increase or decrease in the absorption, respectively, at each of the three 
wavelengths. This increase or decrease in absorption can be observed as an increase or 
decrease, respectively, in the amplitude of the time-domain AC signal and can be 
observed in the corresponding FFT of the AC signal. Figure 11 displays 10-second 
segments of the time domain AC signals measured from the single layer (Figure 11a) 
and multilayer (Figure 11c) parenchymal phantoms along with the FFT of the entire 60-
second data segment. Figure 12 displays a 10-second segment of the time domain AC 
signal measured from porcine liver parenchyma along with the corresponding FFT of the 
entire 60 second data segment. The AC/DC ratio is slightly higher for the multilayer 
phantom, which is expected because the multilayer phantom contains more lobules and 
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is capable of storing a larger volume of dye solution. This increased volume results in a 
larger AC signal measured from the pulsatile flow induced by the peristaltic pumps. 
However, this increased AC signal comes at the expense of less homogeneous waveform 
which is most likely due to the presence of three layers of lobules.  
 
 
 
 
 
Figure 11: 10-second segment of the time-domain AC signal measured from the single 
layer (a) and multilayer (c) parenchymal phantoms along with the corresponding FFT 
spectrum of a 60 second segment of data measured from the single layer (b) and 
multilayer (d) parenchymal phantoms. 
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Figure 12: 10 second segment of the time-domain AC signal measured from porcine 
liver parenchyma (a) along with the FFT of the entire 60 second data segment (b). 
 
 
 
 
Figure 13 displays the normalized values of the FFT peak at 1.667 Hz at each 
wavelength vs. perfusion for the single layer parenchymal phantom. At each wavelength, 
the FFT peak value decreases linearly with a decrease in perfusion of the dye solutions. 
To assess the sensitivity of the phantoms to changes in perfusion, a linear fit was applied 
to the data. For the single layer parenchymal phantom, the slope of the fit at 735 nm, 805 
nm, and 940 nm is 1.07; 1.08; and 1.09, respectively. This observation indicates that the 
absorption at each wavelength increases at approximately the same rate, as is expected 
because the volume per pulse and not the oxygen saturation was altered. 
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Figure 13: Signal measured at 735 nm (a), 805 nm (b), and 940 nm (c) from in vitro 
perfusion experiments on the single layer parenchymal phantom. 
 
 
 
 
Figure 14 displays the normalized values of the FFT peak at 1.667 Hz at each 
wavelength vs. perfusion for the multi-layer parenchymal phantom. As with the single 
layer parenchymal phantom, the FFT peak values at each wavelength decrease linearly 
with a decrease in perfusion. The slope of the linear fit for the 735 nm, 805 nm, and 940 
nm wavelengths is 1.41; 1.36; and 1.34, respectively, indicating that the absorption at 
each wavelength is increasing at the same rate with an increase in perfusion. This same 
observation is true for the single layer parenchymal phantom. However, the slope of the 
linear fit at each wavelength is approximately 30% higher in the multilayer phantom, 
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indicating a higher sensitivity to changes in perfusion with the data collected from the 
multilayer phantom. 
 
 
  
 
 
Figure 14: Signal measured at 735 nm (a), 805 nm (b), and 940 nm (c) from in vitro 
perfusion experiments on the multilayer parenchymal phantom. 
 
 
 
 
As predicted, with a decrease in perfusion, the FFT peak value decreases at each 
of the three wavelengths indicating the presence of less dye solution being pulsed 
through the parenchymal phantoms. Under the same volumetric flow rates per gram of 
tissue, the slope of the data taken from perfusion studies on the multilayer phantom is 
(a) (b) 
(c) 
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greater than that of the single layer phantom indicating a higher sensitivity to changes in 
perfusion and a greater resolution for the sensor. The higher sensitivity in the multilayer 
phantom is expected due to the presence of a higher total volume of dye solution per 
pulse resulting from more lobules being present in the multilayer phantom (1200 
lobules) than in the single layer phantom (400 lobules). This higher volume of dye 
solution results in a better signal (AC/DC; see Figure 11) being extracted from the 
perfusion data. However, although the slopes of the linear fits are roughly the same, the 
values contain slight differences at the different wavelengths for both phantoms. For 
example, the slope of the linear fit for the 735 nm wavelength is less than the slope of 
the linear fit for the 940 nm wavelength for the single layer parenchymal phantom 
(Figure 13). This small difference in the slopes may produce errors in SaO2 values due to 
perfusion. Theoretically, a change in perfusion should not produce a change in the 
measured SaO2, but this difference in slopes at the different wavelengths could result in 
an SaO2 value that decreases with a change in perfusion. While this observation is not a 
problem for experiments limited to perfusion only, when attempting to simultaneously 
measure perfusion and oxygen saturation, the change in SaO2 with perfusion will cause a 
problem. The same problem exists with data gathered from the multi-layer phantom. 
However, an opposite effect could be produced resulting in an SaO2 that increases with 
an increase in perfusion due to the greater slope at the 735 nm wavelength than the 940 
nm wavelength (Figure 14). Figure 15 displays the values of R (Equation 1) vs. 
perfusion. The R value decreases with an increase in perfusion in the single layer 
phantom, which corresponds to an increase in the measured SaO2 as perfusion increases. 
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However, the R value increases with an increase in perfusion in the multi-layer phantom, 
which corresponds to a decrease in the measured SaO2 as perfusion increases. While 
opposite effects were produced with each phantom, the same problem exists. Changes in 
the measured R value indicate changes in SaO2, and this effect would lead to erroneous 
SaO2 measurements in the presence of stable oxygenation with changing perfusion.  
 
 
 
 
Figure 15: R vs. perfusion for in vitro perfusion experiments performed on the single 
layer (a) and multi-layer (b) parenchymal phantoms. 
 
 
 
 
The data gathered from perfusion studies performed on the compliant portal vein 
phantom displays similar trends to the data gathered from perfusion studies performed 
on the parenchymal phantoms (Figure 16). As with the parenchymal phantoms, the FFT 
peak value increases with a increase in perfusion. The FFT peak value increases at the 
same rate for each of the wavelengths, which is expected due to the change in perfusion 
with constant oxygen saturation. 
(a) (b) 
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Figure 16: Signal measured at 735 nm (a), 805 nm (b), and 940 nm (c) from in vitro 
perfusion experiments on the compliant portal vein phantom. 
 
 
 
 
4.4 Occlusion studies 
To assess the ability of both phantoms to mimic liver parenchyma 
physiologically, in vitro occlusion studies were performed to evaluate and compare the 
response of the phantoms in the presence of a blockage in flow to in vivo results 
collected from occlusion studies on a pig liver parenchyma. In each phantom, a 
simulation of 50% and 100% blockage of flow were created by decreasing the 
volumetric flow rates of the peristaltic pumps by 50% and 100%, respectively. For the in 
vivo occlusion study, a total occlusion was created by the use of mechanical occluders on 
both the portal vein and hepatic artery. 
(a) (b) 
(c) 
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4.4.1 In vitro occlusion studies 
Figure 17 displays the results of the in vitro occlusion studies on the single layer 
(Figure 17a) and multilayer (Figure 17b) parenchymal phantoms. During 50% occlusion, 
the signal measured from both phantoms at each wavelength decreases to approximately 
50% of the baseline values. This observation is consistent with the 50% decrease in the 
volumetric flow rate from the peristaltic pump. Also, during total occlusion, the signal at 
each wavelength measured from both phantoms decreases to zero, consistent with the 
100% decrease in flow from the peristaltic pump. The remaining data points indicate the 
ability of both phantoms to recover during fully restored flow. All simulations were 
performed with the dye solution mimicking the absorption properties of HbO2, which 
explains the greater signal for the 940 nm wavelength. Also, the signal measured from 
the multilayer phantom is approximately 3 times greater than the signal measured from 
the single layer phantom, which is consistent with the multilayer phantom containing 
three times as many layers of lobules than the single layer phantom.   
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Figure 17: AC/DC measured during in vitro occlusion studies performed on the single 
layer parenchymal phantom (a) and multi-layer parenchymal phantom (b). The results 
show a decrease in perfusion during simulations of 50% and 100% occlusion of the 
inputs to the phantoms and an increase as the flow is restored. 
 
  
(a) 
(b) 
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4.4.2 In vivo occlusion studies 
Figure 18 displays the results from the in vivo occlusion studies. During 100% 
occlusion, the signal decreases to nearly zero. This significant decrease is consistent with 
the significant decrease in flow induced by mechanical occlusion of the vessels. The 
final data point indicates that the signal recovered to baseline after flow was restored.  
 
 
Figure 18: AC/DC signal measured during in vivo occlusion studies showing a decrease 
in signal during full occlusion and an increase in signal as flow is restored. 
 
 
 
 
4.5 Oxygenation studies 
In vitro oxygenation studies were performed to determine if the sensor and 
phantoms could be used for future oxygenation studies. Varying dye solutions 
mimicking the absorption properties of different hemoglobin oxygen saturations were 
pulsed through the phantoms at a constant volumetric flow rate. It is expected that as the 
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oxygen saturation increases, the ratio of absorbance at 735 nm to absorbance at 940 nm 
will decrease as a result of more oxygenated hemoglobin being present in a specific 
volume of blood. The presence of more oxygenated hemoglobin results in more 940 nm 
wavelength light being absorbed. Figure 5 displays the ratio, R, versus the oxygen 
saturation for the single layer parenchymal phantom. R decreases as oxygen saturation 
increases for the single layer parenchymal phantom as well as the multilayer 
parenchymal phantom (Figures 19 and 20). The slopes of the linear fit for the oxygen 
saturations 60% and above on both phantoms are identical, indicating that the number of 
sinusoid layers does not affect the R values measured during the oxygenation studies.  
 
 
 
 
 Figure 19: Ratio, R, vs. oxygen saturation for the single layer parenchymal phantom (a) 
and a cutout showing the data from 60-100% oxygenation (b). 
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Figure 19: Continued. 
 
 
 
 
Figure 20: Ratio, R, vs. oxygen saturation for the multilayer parenchymal phantom (a) 
and a cutout showing the data from 60-100% oxygenation (b). 
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Figure 20: Continued. 
 
 
 
 
It was noted earlier that the R value changes in response to a change in perfusion 
(Figure 15). While the range of R values over the change in perfusion is relatively small 
(in comparison to measured R values for traditional pulse oximeters), this range could 
prove problematic when calibrating the sensor in an attempt to simultaneously measure 
perfusion and oxygenation in vitro due to the small range of R values measured from the 
in vitro oxygenation experiments. For instance, the range of R values of Figure 15 is 
0.042 and 0.072 for the single and multi-layer phantoms, respectively. However, the 
range of R values within the physiologic range of interest (Figure 19b and 20b) for the 
single and multi-layer parencymal phantoms is 0.291 and 0.271, respectively. The 
changes in R induced by changes in perfusion represent 15%  and 17% of the range of R 
values for the single layer and  multi-layer phantom, respectively. Such a range of R 
values could lead to erroneous SaO2 measurements by the sensor system. 
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CHAPTER V  
CONCLUSIONS AND FUTURE WORK 
Phantoms mimicking the optical properties of liver parenchyma have been 
developed for use with in vitro perfusion and oxygenation experiments. Development of 
such phantoms should aid in facilitating sensor design while reducing the number of 
animal experiments needed. In this work, data gathered during in vitro perfusion and 
occlusion studies performed on single and multilayer parenchymal phantoms were 
compared to data gathered from in vivo occlusion studies performed on a female swine. 
Also, the optical coupling to the surface of the PDMS-based phantoms and the 
compliance of the phantoms were assessed. It was shown that the use of optical coupling 
gel resulted in more light collected by the photodetector when compared with 
measurements taken without the use of optical coupling gel. Also, it was shown that by 
designing a more compliant portal vein phantom with no rigid plastic tube in the center, 
the system was able to measure a well-defined AC waveform.  The ability to measure an 
AC signal and a peak in the FFT spectrum that corresponded to the pump frequency 
(1.667 Hz) in both parenchymal phantoms and the portal vein phantom was shown.  
In the parenchymal and portal vein phantoms, the FFT peak value decreased as 
the volumetric flow rate of the dye solutions through the phantoms decreased. Both the 
single layer and multilayer parenchymal phantoms displayed the same trends in the 
occlusion studies as the liver parenchyma, but the signal measured with the multilayer 
phantom was higher than the signal measured with the single layer parenchymal 
phantom. The signal measured with the multilayer parenchymal phantom was nearly 
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three times higher than the single layer phantom and showed greater sensitivity to 
changes in perfusion. These observations demonstrate the ability of the single layer and 
multilayer phantom to be used for in vitro studies to facilitate sensor design. These 
observations also confirm that it is more applicable to use the multilayer phantom 
because it more closely mimics the anatomical properties of liver parenchyma but is only 
slightly more complex in design than the single layer parenchymal phantom. While 
adding more layers of sinusoids (until the depth of the layers exceeds the penetration 
depth of the light) should provide an even better response, the addition of more layers 
will add to the complexity of the phantom due to the number of input and output ports 
that would be required. Each additional layer would require the addition of three 
input/output ports or a different design with vertical interconnects between the sinusoid 
layers could be pursued. 
In vitro oxygenation studies were performed on the single layer and multilayer 
parenchymal phantoms to determine if the phantoms could be used for future 
oxygenation studies. As the oxygenation increased, the ratio, R, decreased for both 
phantoms, and showed a similar range of values. Within the physiologic range of interest 
for oxygenation percentage (60-100% oxygenation), the slopes of the linear fits of both 
phantoms were identical indicating an identical sensitivity to changes in oxygenation. 
For future oxygenation studies, it may be more applicable to use the single layer 
parenchymal phantom because it only has three input ports making it easier to load fluid 
into and pump fluid through the lobules. 
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Future work should focus on miniaturization of the sensor system for 
implantation and redesigning the probe to make it more suitable to attach to the tissue 
and to vessels during in vivo experiments. Studies should be performed to assess the 
upper and lower limits of detection as well. Also, the compliance of the PDMS should be 
adjusted to match the compliance of the portal vein and liver parenchyma (where 
applicable) if possible. 
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APPENDIX A 
MATLAB PROGRAM FFT Program.m 
 
Fs = 300; 
T = 1/Fs; 
A_735 = A(:,2); 
A_805 = A(:,3); 
A_940 = A(:,4); 
L = length(A(:,1)); 
L_735 = length(A_735); 
L_805 = length(A_805); 
L_940 = length(A_940); 
t = (0:L-1)*T; 
NFFT_735 = 2^nextpow2(L_735); 
NFFT_805 = 2^nextpow2(L_805); 
NFFT_940 = 2^nextpow2(L_940); 
Y_735 = fft(A_735,NFFT_735)/L_735; 
Y_805 = fft(A_805,NFFT_805)/L_805; 
Y_940 = fft(A_940,NFFT_940)/L_940; 
f_735 = Fs/2*linspace(0,1,NFFT_735/2+1); 
f_805 = Fs/2*linspace(0,1,NFFT_805/2+1); 
f_940 = Fs/2*linspace(0,1,NFFT_940/2+1); 
 
figure; plot(f_735,2*abs(Y_735(1:NFFT_735/2+1))); xlabel('Frequency 
(Hz)'); ylabel('Power'); title('735 nm FFT Single Layer Parenchymal 
Phantom'); set(gca,'XLim',[0 5]); 
 
figure; plot(f_805,2*abs(Y_805(1:NFFT_805/2+1))); xlabel('Frequency 
(Hz)'); ylabel('Power'); title('805 nm FFT Single Layer Parenchymal 
Phantom'); set(gca,'XLim',[0 5]); 
 
figure; plot(f_940,2*abs(Y_940(1:NFFT_940/2+1))); xlabel('Frequency 
(Hz)'); ylabel('Power'); title('940 nm FFT Single Layer Parenchymal 
Phantom'); set(gca,'XLim',[0 5]); 
  
figure; plot(A(1:3000,1),A(1:3000,2)); xlabel('Time (Seconds)'); 
ylabel('AC Voltage (Volts)'); title('735 nm AC Signal'); 
 
figure; plot(A(1:3000,1),A(1:3000,3)); xlabel('Time (Seconds)'); 
ylabel('AC Voltage (Volts)'); title('805 nm AC Signal'); 
 
figure; plot(A(1:3000,1),A(1:3000,4)); xlabel('Time (Seconds)'); 
ylabel('AC Voltage (Volts)'); title('940 nm AC Signal'); 
  
FFT_735 = 2*abs(Y_735(1:NFFT_735/2+1)); 
FFT_805 = 2*abs(Y_805(1:NFFT_805/2+1)); 
FFT_940 = 2*abs(Y_940(1:NFFT_940/2+1)); 
FFT = [FFT_735 FFT_805 FFT_940]; 
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AC_735 = 2*abs(Y_735(1:NFFT_735/2+1)); 
AC_805 = 2*abs(Y_805(1:NFFT_805/2+1)); 
AC_940 = 2*abs(Y_940(1:NFFT_940/2+1)); 
  
AC = [AC_735(183,1) AC_805(183,1) AC_940(183,1)]; 
DC = [mean(A(:,5)) mean(A(:,6)) mean(A(:,7))]; 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% END OF THE PROGRAM TO TAKE THE FFT OF THE DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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